Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Patheon Completes ISPS Expansion | Contract Pharma

What are you searching for?

Sign in
Breaking News

Patheon Completes ISPS Expansion

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Patheon has completed its expansion of services using a new Intermediate Scale Processing Suite (ISPS) at its Cincinnati, OH facility. The ISPS provides increased manufacturing capacity, bridging the company’s development and commercial scale facilities.
   
The ISPS equipment includes an intermediate scale Diosna-P300 high shear granulator coupled with Niro-MP4 fluid bed dryer with solvent and high potency compound handling capabilities. This suite will allow the production of batch sizes ranging from 35-115 kg. The ISPS will allow the company to provide development, clinical, registration, scale-up, validation and commercial services to customers. The ISPS provides greater flexibility in scheduling experiments on a larger scale, using less active pharmaceutical ingredients (API) compared to commercial scale, according to the company.

Terry Novak, Patheon’s president, North America and chief marketing officer, stated, “The ISPS provides us with another valuable service to address the unique needs of our customers. By adding this equipment we will be able to reduce time and resources it takes to moving a new product though development.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics